Developing new contraceptive methods for women, especially those who are obese.
CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM – CORE FUNCTION ACTIVITIES FOR SITES OF FEMALE CONTRACEPTIVE STUDIES - HAWAII-MANOA
This study is looking for new birth control methods that can help prevent unintended pregnancies while being safer for women who are obese, and by joining the trials, you could try out these new options designed just for your health needs.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Hawaii at Manoa NIH-funded |
| Lab location | 1 site (Honolulu, United States) |
| Project ID | NIH-11127345 on NIH RePORTER |
What this research studies
This research focuses on creating new contraceptive methods that effectively prevent unintended pregnancies while also minimizing the risk of venous thromboembolism (VTE), particularly in obese women. The Contraceptive Clinical Trials Network (CCTN) will develop protocols and conduct clinical trials to test these new contraceptive agents. By participating in these trials, women may have access to innovative contraceptive options that are tailored to their specific health needs.
Who could benefit from this research
Good fit: Ideal candidates for this research include women seeking effective contraception, especially those who are obese or have medical conditions that make current contraceptive methods unsuitable.
Not a fit: Patients who are not seeking contraception or who do not have any health concerns related to current contraceptive methods may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective contraceptive options for women, particularly those at higher risk due to obesity.
How similar studies have performed: Previous research has shown promise in developing new contraceptive methods, but this specific approach targeting obese women is relatively novel.
Where this research is happening
Honolulu, United States
- University of Hawaii at Manoa — Honolulu, United States (Active)
Researchers
- Principal investigator: Kaneshiro, Bliss E — University of Hawaii at Manoa
- Study coordinator: Kaneshiro, Bliss E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.